Form 4: Ardent Health COO Dave Caspers Equity Transaction

Ardent Health COO Dave Caspers reported the vesting of restricted stock units and a related tax withholding transaction.

Summary

• Dave Caspers, Chief Operating Officer of Ardent Health, Inc., engaged in two transactions on April 1, 2026.
• The company withheld 2,684 shares of common stock to satisfy tax obligations related to the vesting of restricted stock units.
• The reporting person was granted 35,673 restricted stock units, which will vest in three equal annual installments starting April 1, 2026.
• Following these transactions, the reporting person holds a total of 71,277 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard executive compensation practices.

Positives

• The transaction reflects the vesting of equity-based compensation, aligning the executive's interests with long-term shareholder value.

Negatives

• The withholding of 2,684 shares represents a reduction in potential direct ownership to cover tax liabilities.

Risks

• Future vesting of the 35,673 restricted stock units is contingent upon the reporting person's continued service with the issuer.

Future Outlook

The 35,673 restricted stock units granted will vest in three substantially equal installments on each anniversary of April 1, 2026, subject to continued service.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of executive compensation and does not indicate a change in the company's strategic direction or financial health.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a component of executive compensation is standard practice among publicly traded healthcare companies to ensure retention and performance alignment.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the remaining restricted stock units in annual installments starting April 1, 2027.

Key Dates

Keywords

Ardent Health, ARDT, Form 4, Insider Trading, Equity Compensation, COO